David Shook - Jan 1, 2023 Form 3 Insider Report for Nkarta, Inc. (NKTX)

Role: Chief Medical Officer
Signature: /s/ Alicia Hager, as Attorney-in-Fact
Stock symbol: NKTX
Transactions as of: Jan 1, 2023
Transactions value $: $0
Form type: 3
Date filed: 1/10/2023, 03:14 PM
Next filing: Jan 18, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	NKTX	Common Stock						23K	Jan 1, 2023	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	NKTX	Stock Option (right to buy)							Jan 1, 2023	Common Stock	13.3K	$18.00	Direct	F2
holding	NKTX	Stock Option (right to buy)							Jan 1, 2023	Common Stock	4.3K	$18.00	Direct	F3
holding	NKTX	Stock Option (right to buy)							Jan 1, 2023	Common Stock	4.8K	$18.00	Direct	F4
holding	NKTX	Stock Option (right to buy)							Jan 1, 2023	Common Stock	4.68K	$54.89	Direct	F5
holding	NKTX	Stock Option (right to buy)							Jan 1, 2023	Common Stock	150	$31.85	Direct	F6
holding	NKTX	Stock Option (right to buy)							Jan 1, 2023	Common Stock	3.31K	$12.14	Direct	F7
holding	NKTX	Stock Option (right to buy)							Jan 1, 2023	Common Stock	5K	$18.44	Direct	F8
holding	NKTX	Stock Option (right to buy)							Jan 1, 2023	Common Stock	7K	$13.86	Direct	F9
holding	NKTX	Stock Option (right to buy)							Jan 1, 2023	Common Stock	35K	$12.25	Direct	F10
holding	NKTX	Stock Option (right to buy)							Jan 1, 2023	Common Stock	30K	$16.46	Direct	F11

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Includes 1,660 Restricted Stock Units ("RSUs") which vest in four equal annual installments beginning on January 14, 2023, 5,000 RSUs which vest in four equal annual installments beginning on June 17, 2023, and 15,000 RSUs which vest in four equal annual installments beginning on August 20, 2023. Each RSU represents a contingent right to receive one share of Common Stock of the Issuer.
F2	The option is vested and exercisable as to 8,589 shares, and the remaining shares will vest and become exercisable ratably in monthly installments until fully vested on June 1, 2024.
F3	The option is vested and exercisable as to 2,687 shares, and the remaining shares will vest and become exercisable ratably in monthly installments until fully vested on July 1, 2024.
F4	The option is vested and exercisable as to 3,000 shares, and the remaining shares will vest and become exercisable ratably in monthly installments until fully vested on July 9, 2024.
F5	The option is vested and exercisable as to 2,340 shares, and the remaining shares will vest and become exercisable ratably in monthly installments until fully vested on January 8, 2025.
F6	The option is vested and exercisable as to 62 shares, and the remaining shares will vest and become exercisable ratably in monthly installments until fully vested on April 30, 2025.
F7	The option is vested and exercisable as to 759 shares, and the remaining shares will vest and become exercisable ratably in monthly installments until fully vested on January 14, 2026.
F8	The option is vested and exercisable as to 833 shares, and the remaining shares will vest and become exercisable ratably in monthly installments until fully vested on April 29, 2026.
F9	The option is vested and exercisable as to 1,021 shares, and the remaining shares will vest and become exercisable ratably in monthly installments until fully vested on May 16, 2026.
F10	The option is vested and exercisable as to 4,375 shares, and the remaining shares will vest and become exercisable ratably in monthly installments until fully vested on June 17, 2026.
F11	The option is vested and exercisable as to 2,500 shares, and the remaining shares will vest and become exercisable ratably in monthly installments until fully vested on August 20, 2026.